Split Views in France: Over 30% Of Dental Prostheses On The Market Imported From China

Paris, 22 October - A public debate has emerged within France's dental technology sector over the growing volume of offshore dental restorations coming into the country.

According to UNPPD, the French national union of dental prosthetics manufacturers, more than 30% of dental prostheses sold on the French market are now produced by dental laboratories in China. The union warned that regulatory oversight of these overseas production sites poses practical challenges for French authorities.

UNPPD pointed out that domestic dental labs in France are subject to regular on-site inspections by ANSM, the French national agency for the safety of medicines and health products, covering raw materials, manufacturing workflows, quality records and finished-product controls. By contrast, it is difficult for French and EU regulators to carry out routine on-site audits at Chinese dental facilities. While imported restorations are required to hold conformity documentation, the union argued that real-time process verification and full traceability remain harder to guarantee, potentially creating patient safety risks. The organisation also noted that low-cost offshore production is diverting work from local French labs and putting pressure on domestic dental technicians and traditional craftsmanship.

The French Dental Association (CDF) has put forward a contrasting position. It stressed that the country of origin alone should not be used to judge product quality. Under the EU Medical Device Regulation (MDR 2017/745), imported dental prostheses that complete all conformity assessment procedures and meet mandatory safety, biocompatibility and performance requirements are legally authorised for use in France, even at lower price points.

CDF explained that dentists bear clinical responsibility for verifying conformity documentation and checking the suitability of each restoration for individual patients. There is no "local preference" rule written into the regulation. The association agreed that improved cross-border traceability is beneficial for patient protection, and supports strengthening importer accountability under the existing MDR framework, rather than a blanket ban on compliant overseas products.

The clash highlights a long-running structural tension in digital dental workflows. Intraoral scanning and remote data transfer have made cross-border outsourcing of dental production commonplace. Local manufacturers are calling for stricter cross-border inspection and fair competition rules, while clinical representatives uphold unified EU regulatory standards and defend patients' right to affordable treatment options.

Industry observers expect the discussion may push French regulators to refine traceability and random-check rules for non-EU dental imports. At the time of publication, no new regulatory changes have been announced by the authorities in response to UNPPD's concerns.